177 related articles for article (PubMed ID: 10421266)
1. Multidrug resistance modulators and doxorubicin synergize to elevate ceramide levels and elicit apoptosis in drug-resistant cancer cells.
Lucci A; Han TY; Liu YY; Giuliano AE; Cabot MC
Cancer; 1999 Jul; 86(2):300-11. PubMed ID: 10421266
[TBL] [Abstract][Full Text] [Related]
2. SDZ PSC 833, the cyclosporine A analogue and multidrug resistance modulator, activates ceramide synthesis and increases vinblastine sensitivity in drug-sensitive and drug-resistant cancer cells.
Cabot MC; Giuliano AE; Han TY; Liu YY
Cancer Res; 1999 Feb; 59(4):880-5. PubMed ID: 10029079
[TBL] [Abstract][Full Text] [Related]
3. Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells.
Lavie Y; Cao Ht; Volner A; Lucci A; Han TY; Geffen V; Giuliano AE; Cabot MC
J Biol Chem; 1997 Jan; 272(3):1682-7. PubMed ID: 8999846
[TBL] [Abstract][Full Text] [Related]
4. The multidrug resistance modulator SDZ PSC 833 is a potent activator of cellular ceramide formation.
Cabot MC; Han TY; Giuliano AE
FEBS Lett; 1998 Jul; 431(2):185-8. PubMed ID: 9708899
[TBL] [Abstract][Full Text] [Related]
5. SDZ PSC 833 the drug resistance modulator activates cellular ceramide formation by a pathway independent of P-glycoprotein.
Goulding CW; Giuliano AE; Cabot MC
Cancer Lett; 2000 Feb; 149(1-2):143-51. PubMed ID: 10737718
[TBL] [Abstract][Full Text] [Related]
6. Modification of ceramide metabolism increases cancer cell sensitivity to cytotoxics.
Lucci A; Han TY; Liu YY; Giuliano AE; Cabot MC
Int J Oncol; 1999 Sep; 15(3):541-6. PubMed ID: 10427137
[TBL] [Abstract][Full Text] [Related]
7. Multidrug resistance modulators PSC 833 and CsA show differential capacity to induce apoptosis in lymphoid leukemia cell lines independently of their MDR phenotype.
Lopes EC; Garcia M; Benavides F; Shen J; Conti CJ; Alvarez E; Hajos SE
Leuk Res; 2003 May; 27(5):413-23. PubMed ID: 12620293
[TBL] [Abstract][Full Text] [Related]
8. Lactoferricin-induced apoptosis in estrogen-nonresponsive MDA-MB-435 breast cancer cells is enhanced by C6 ceramide or tamoxifen.
Furlong SJ; Mader JS; Hoskin DW
Oncol Rep; 2006 May; 15(5):1385-90. PubMed ID: 16596215
[TBL] [Abstract][Full Text] [Related]
9. Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism.
Maurer BJ; Melton L; Billups C; Cabot MC; Reynolds CP
J Natl Cancer Inst; 2000 Dec; 92(23):1897-909. PubMed ID: 11106681
[TBL] [Abstract][Full Text] [Related]
10. Ceramide toxicity and metabolism differ in wild-type and multidrug-resistant cancer cells.
Lucci A; Giuliano AE; Han TY; Dinur T; Liu YY; Senchenkov A; Cabot MC
Int J Oncol; 1999 Sep; 15(3):535-40. PubMed ID: 10427136
[TBL] [Abstract][Full Text] [Related]
11. Enhanced de novo ceramide generation through activation of serine palmitoyltransferase by the P-glycoprotein antagonist SDZ PSC 833 in breast cancer cells.
Wang H; Giuliano AE; Cabot MC
Mol Cancer Ther; 2002 Jul; 1(9):719-26. PubMed ID: 12479368
[TBL] [Abstract][Full Text] [Related]
12. Ceramide glycosylation potentiates cellular multidrug resistance.
Liu YY; Han TY; Giuliano AE; Cabot MC
FASEB J; 2001 Mar; 15(3):719-30. PubMed ID: 11259390
[TBL] [Abstract][Full Text] [Related]
13. Expression of P-glycoprotein in HeLa cells confers resistance to ceramide cytotoxicity.
Chapman JV; Gouazé-Andersson V; Cabot MC
Int J Oncol; 2010 Dec; 37(6):1591-7. PubMed ID: 21042729
[TBL] [Abstract][Full Text] [Related]
14. Disruption of mitochondrial membrane potential during apoptosis induced by PSC 833 and CsA in multidrug-resistant lymphoid leukemia.
Bustamante J; Caldas Lopes E; Garcia M; Di Libero E; Alvarez E; Hajos SE
Toxicol Appl Pharmacol; 2004 Aug; 199(1):44-51. PubMed ID: 15289089
[TBL] [Abstract][Full Text] [Related]
15. Alteration of the daunorubicin-triggered sphingomyelin-ceramide pathway and apoptosis in MDR cells: influence of drug transport abnormalities.
Côme MG; Bettaieb A; Skladanowski A; Larsen AK; Laurent G
Int J Cancer; 1999 May; 81(4):580-7. PubMed ID: 10225448
[TBL] [Abstract][Full Text] [Related]
16. Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance.
Liu YY; Han TY; Giuliano AE; Hansen N; Cabot MC
J Biol Chem; 2000 Mar; 275(10):7138-43. PubMed ID: 10702281
[TBL] [Abstract][Full Text] [Related]
17. Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833.
Beketic-Oreskovic L; Durán GE; Chen KG; Dumontet C; Sikic BI
J Natl Cancer Inst; 1995 Nov; 87(21):1593-602. PubMed ID: 7563202
[TBL] [Abstract][Full Text] [Related]
18. Selective susceptibility of transformed T lymphocytes to induction of apoptosis by PSC 833, an inhibitor of P-glycoprotein.
Azare J; Pankova-Kholmyansky I; Salnikow K; Cohen D; Flescher E
Oncol Res; 2001; 12(8):315-23. PubMed ID: 11589302
[TBL] [Abstract][Full Text] [Related]
19. Combined use of tamoxifen, cyclosporin A, and verapamil for modulating multidrug resistance in human hepatocellular carcinoma cell lines.
Kim JH; Chung JB; Park IS; Kim BS; Yoo NC; Choi JH; Roh JK; Kim HS; Kwon OH; Lee KS
Yonsei Med J; 1993 Mar; 34(1):35-44. PubMed ID: 8397460
[TBL] [Abstract][Full Text] [Related]
20. Increasing intracellular ceramide: an approach that enhances the cytotoxic response in prostate cancer cells.
Wang H; Charles AG; Frankel AJ; Cabot MC
Urology; 2003 May; 61(5):1047-52. PubMed ID: 12736045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]